Foghorn Therapeutics
FHTX
FHTX
60 hedge funds and large institutions have $357M invested in Foghorn Therapeutics in 2022 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 20 increasing their positions, 14 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 61 → 60 (-1)
6% less capital invested
Capital invested by funds: $379M → $357M (-$21.7M)
Holders
60
Holding in Top 10
3
Calls
$2K
Puts
–
Top Buyers
1 | +$7.33M | |
2 | +$5.04M | |
3 | +$3.24M | |
4 |
Morgan Stanley
New York
|
+$2.62M |
5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2M |
Top Sellers
1 | -$892K | |
2 | -$826K | |
3 | -$725K | |
4 |
BlackRock
New York
|
-$448K |
5 |
![]()
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$396K |